Skip to main content
. 2020 Nov 13;9(11):1125. doi: 10.3390/antiox9111125

Table 1.

Population characteristics (n = 116).

Variable Mean (SD) or n (%)
Age (years) 58.53 (18.12)
Sex (% female) 59 (50.90)
Morbidity N of patients with morbidity/Total population
Myocardial infarction, n (%) 12 (10.30)
Heart failure, n (%) 4 (3.40)
Peripheral vascular disease, n (%) 7 (6.00)
Diabetes mellitus, n (%) 13 (11.20)
Cerebrovascular disease, n (%) 10 (8.60)
Dementia, n (%) 5 (4.30)
Chronic obstructive pulmonary disease n (%) 9 (7.80)
Connective tissue disease, n (%) 13 (11.20)
Renal disease, n (%) 6 (5.20)
Hematologic cancer, n (%) 1 (0.90)
Solid tumoral disease, n (%) 15 (12.90)
Co-morbidities (sum of diseases) 0.93 (1.06)
Frequent medications
Antihypertensive drugs 38 (32.76%)
Lipid-lowering drugs 21 (18.10%)
Anti-diabetic drugs 6 (5.17%)
Oxidant lifestyle
Dietary oxidant habits (yes) 57 (49.10)
Absence of exercise (yes) 24 (20.70)
Antioxidative lifestyle * 51 (44.00)
Intermediate lifestyle ** 49 (42.20)
Prooxidant lifestyle *** 16 (13.80)
Hepatic liver fibrosis
Quality of life SF-36 categories (0–100)
Physical 78.55 (28.60)
Physical role 76.75 (25.38)
Emotional role 86.67 (21.58)
Mental 69.90 (20.19)
Social 78.62 (26.25)
Vitality 55.56 (22.58)
Pain 64.18 (27.12)
General 55.00 (20.19)
Physical summary 63.17 (22.68)
FIB-4 index (points) 0.65 (0.57)

* Neither oxidative dietary nor activity habits, ** Either oxidative dietary or activity habits, *** Both dietary and activity oxidative habits. See Appendix A Table A1.